Largimox

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic effective against Gram-positive, Gram-negative, and atypical bacteria. It is commonly indicated for respiratory tract infections, skin infections, and intra-abdominal infections. It inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death.